Skip to main content
Equibles

GRANDFIELD & DODD, LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1308016 NEW YORK, NY
Back to BMRN Full portfolio

Position in BMRN

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,043,864
+$34,897 QoQ
Shares Held
18,243
+2.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#274
of 565 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GRANDFIELD & DODD, LLC holds $46,143,038 across 12 Biotechnology names. BMRN ranks #6 (2.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 36,628 $22,839,023
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 24,838 $12,337,779
3 IONS
Ionis Pharmaceuticals Inc
 37,077 $2,939,835
4 INCY
Incyte Corp
 20,822 $2,360,381
5 EXEL
Exelixis, Inc.
 27,109 $1,475,000
6 BMRN
Biomarin Pharmaceutical Inc
This page 		18,243 $1,043,864
7 GMAB
Genmab A/S
 37,633 $1,033,778
8 ALNY
Alnylam Pharmaceuticals, Inc.
 3,204 $964,500

All Filings in BMRN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,043,864 18,243
2026-03-31 $1,008,967 17,861
2025-12-31 $1,078,713 18,151
2025-09-30 $1,027,252 18,967
2025-06-30 $1,030,687 18,750
2025-03-31 $1,322,751 18,712
2024-12-31 $1,143,176 17,392
2024-09-30 $1,171,101 16,661
2024-06-30 $1,336,709 16,236
2024-03-31 $1,408,532 16,127
2023-12-31 $1,530,378 15,872
2023-09-30 $1,384,977 15,653
2023-06-30 $1,367,637 15,778
2023-03-31 $1,520,930 15,641
2022-12-31 $1,594,780 15,410
2022-09-30 $1,218,399 14,373
2022-06-30 $1,160,262 14,001
2022-03-31 $1,073,694 13,926
2021-12-31 $1,190,074 13,470
2021-09-30 $937,759 12,133
2021-06-30 $979,084 11,734
2021-03-31 $869,799 11,519
2020-12-31 $985,547 11,239
2020-09-30 $821,664 10,800
2020-06-30 $1,311,474 10,633
2020-03-31 $839,761 9,938